UK markets closed
  • NIKKEI 225

    26,992.21
    +776.42 (+2.96%)
     
  • HANG SENG

    17,079.51
    -143.32 (-0.83%)
     
  • CRUDE OIL

    86.37
    +2.74 (+3.28%)
     
  • GOLD FUTURES

    1,734.70
    +32.70 (+1.92%)
     
  • DOW

    30,316.32
    +825.43 (+2.80%)
     
  • BTC-GBP

    17,742.13
    +617.20 (+3.60%)
     
  • CMC Crypto 200

    460.91
    +15.47 (+3.47%)
     
  • ^IXIC

    11,176.41
    +360.97 (+3.34%)
     
  • ^FTAS

    3,873.21
    +99.41 (+2.63%)
     

Unaudited NAV for July 2022

·1-min read

Arix Bioscience PLC (ARIX)
Unaudited NAV for July 2022
12-Aug-2022 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

 

Arix Bioscience plc

 

Unaudited NAV for July 2022

 

LONDON, 12 August 2022: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, announces the unaudited Net Asset Value (“NAV”) of the Company for the date ended 31 July 2022 as follows:

 

Date

NAV Breakdown

Total NAV

 

NAV per share

Listed Portfolio

Unlisted Portfolio

Cash

Other Interests

31 July 22

(unaudited)

£38.5m

£55.7m

£130.8m

£2.0m

£227.0m

£1.76

 

 

[ENDS]

 

Enquiries

For more information on Arix, please contact:

 

Arix Bioscience plc

+44 (0)20 7290 1050

ir@arixbioscience.com

 

Powerscourt Group

Sarah MacLeod, Ibrahim Khalil, Nick Johnson

+44 (0)20 7250 1446

arix@powerscourt-group.com

 

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting-edge advances in life sciences.

 

We collaborate with exceptional entrepreneurs and provide the capital, expertise, and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com

 

 


ISIN:

GB00BD045071

Category Code:

MSCM

TIDM:

ARIX

LEI Code:

213800OVT3AHQCXNIX43

OAM Categories:

3.1. Additional regulated information required to be disclosed under the laws of a Member State

Sequence No.:

180898

EQS News ID:

1419021


 

End of Announcement

EQS News Service

show this
show this